Medical News

RSS

Oral drug baricitinib shows promise in slowing early type 1 diabetes progression

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.

19 Sep 2025

New cryopreservation technique reduces cracking risk in organ freezing

Cryopreservation, or preserving biological tissue by cooling it to subzero temperatures, may bring to mind works of science fiction.

19 Sep 2025

Newly developed metamaterial can potentially transform ingestible and implantable medical devices

Researchers led by Rice University's Yong Lin Kong have developed a soft but strong metamaterial that can be controlled remotely to rapidly transform its size and shape.

19 Sep 2025

Top ten research priorities for childhood deafness identified in new UK project

Deaf children and people with experience of childhood deafness from across the UK have come together to highlight what matters most to children affected by deafness and hearing loss, as part of a project funded by the National Deaf Children's Society (NDCS).

19 Sep 2025

New research links postictal symptoms in epilepsy to hidden brain waves

In everyday clinical practice, symptoms are regularly observed after epileptic seizures, known as "post-ictal symptoms", which, in contrast to the usually short duration of seizures, typically last several minutes to hours. Besides symptoms such as impaired speech and language comprehension, a state of disorientation may occur.

19 Sep 2025

WHO's new report highlights the urgent need to address NCDs and mental health

The World Health Organization (WHO) today released a new report titled "Saving lives, spending less", revealing that an additional investment of just US$3 per person annually in tackling noncommunicable diseases (NCDs) could yield economic benefits of up to US$1 trillion by 2030.

19 Sep 2025

AGA releases new clinical guideline for diagnosing and managing gastroparesis

The American Gastroenterological Association (AGA) has released a new clinical guideline with 12 conditional recommendations for diagnosing and managing gastroparesis, a serious and often debilitating disease.

19 Sep 2025

$Kennedy’s take on vaccine science fractures cohesive national public health strategies$

Kennedy’s take on vaccine science fractures cohesive national public health strategies

Health and Human Services Secretary Robert F. Kennedy Jr. has had a busy few months. He fired the director of the Centers for Disease Control and Prevention, purged the agency's vaccine advisory committee, and included among the group's new members appointees who espouse anti-vaccine views.

19 Sep 2025

Exactech will pay $8M to settle lawsuits over defective knee implant parts

19 Sep 2025

Vitamin D and multivitamins in pregnancy may be linked to lower ADHD and ASD traits

Maternal intake of vitamin D and multivitamins during pregnancy may lower ADHD and autism traits in children, emphasizing the role of nutrition in development.

19 Sep 2025

Can eating style affect how well GLP-1 drugs control diabetes and weight?

Research indicates that external eating behavior is a key predictor of weight loss in type 2 diabetes patients receiving GLP-1 receptor agonists.

19 Sep 2025

App boosts antibiotic prescribing safety in outpatient clinics

A smartphone app integrating antibiotic guidelines improved prescribing practices and adherence to antimicrobial stewardship in Abu Dhabi's outpatient settings.

19 Sep 2025

Closed Loop Medicine launches first personalized GLP-1 dosing platform In U.S.

Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.

19 Sep 2025

INTEGRA Biosciences unveils the SWITCH hybrid pipette combining manual control with fast electronic aliquoting

INTEGRA Biosciences is excited to announce the launch of its new SWITCH hybrid pipette, available from September 2025.

19 Sep 2025

CHOP researchers unveil framework for boosting children's oral health

Researchers from Children's Hospital of Philadelphia (CHOP) demonstrated how a multifaceted intervention approach significantly improved the rate of dental varnish applications to help strengthen tooth enamel and prevent decay.

19 Sep 2025

AI tool analyzes brain activity to support and prioritize autism assessments

Scientists have developed and tested a deep-learning model that could support clinicians by providing accurate results and clear, explainable insights – including a model-estimated probability score for autism.

19 Sep 2025

New findings support low-dose ATG to delay progression of type 1 diabetes

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

19 Sep 2025

Study uncovers new strategy to boost life-saving cervical cancer screenings

Cervical cancer is the fourth most common cancer among women globally, according to the World Health Organization. It accounted for 660,000 new cases and 350,000 deaths in 2022.

19 Sep 2025

New research aims to use eyedrops to lower lifetime risk of nearsightedness complications

For the first time, researchers are leading a national study to see if the onset of nearsightedness can be delayed – and consequently reduced in magnitude over a lifetime – with the use of eyedrops in young children.

19 Sep 2025

Genomic testing speeds patient accrual in high-risk prostate cancer trial

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed accrual and met its accrual milestone of 2,478 patients approximately two years earlier than the trial's anticipated accrual completion date.

19 Sep 2025